Priority Review decision is based on phase III MAJESTY results, where Gazyva/Gazyvaro achieved significantly higher complete remission rates at two...
BEND, OR / ACCESS Newswire / July 14, 2026 / The Veterinary Referral Center of Central Oregon (VRCCO) is proud...
Fully non-hallucinogenic, oral, non-scheduled 5-HT2A neuroplastogen differentiates BETR-001 from every other 5-HT2A agonist program; depression and other psychiatric disorders retained...
BRIDGEWATER, N.J., July 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it...
The Elecsys IGRA TB test expands global access to tuberculosis infection testing, advancing progress toward the World Health Organization's elimination...
Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) migraineDysport is...
Two whole-head MEG systems sit side by side, giving researchers a real-time window into how two brains interact during natural...
Calgary, Alberta--(Newsfile Corp. - July 8, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company"), the leading...
PITTSBURGH, July 07, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech, a leader in nuclear medicine and molecular imaging solutions, today announced...
CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of...
Phase 3 EPIDYS MRI data quantify givinostat’s potential to preserve functional muscle tissue and reduce fat infiltration in patients with...
Collaboration adds brain-based sleep measurement to the NeuLogiq® multi-modal platformBELFAST, Northern Ireland, DUBLIN and TORONTO, July 6, 2026 /PRNewswire/ -- Cumulus...
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, commercialization and HEOR, emerging market, food ingredients...
First gene replacement therapy in the EU for broad population with SMA, including children two years and older, teens and...
Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated advanced KRAS G12C non-small cell lung cancer Divarasib showed...
NEWARK, Del., June 30, 2026 /PRNewswire/ -- The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is...
Florida's premier health information management conference welcomes hundreds of healthcare professionals to Orlando, July 12–15, 2026.ORLANDO, Fla., June 30, 2026...
In this free webinar brought to you by Xtalks Life Sciences United (XLSU), see how advocacy perspectives can help shape...
Expands Just – Evotec Biologics partner-enablement and technology licensing model for proprietary continuous manufacturing platformEnables deployment of continuous manufacturing platform...
This marks the fourth R&D milestone achieved under the collaboration, and the second in 2026, reflecting the steady progress of...